
Please try another search
Insulet Corporation (NASDAQ: PODD) posted a Q2 net loss of $(35) million, or an EPS loss of $(0.50) compared to $(0.37) a year ago. Q2 sales increased 13.8% Y/Y, or 17.7% in constant currency, to...
Insulet (NASDAQ:PODD) reported Q2 EPS of ($0.50), which may not compare to the analyst estimate of $0.22. Revenue for the quarter came in at $299.4 million versus the consensus estimate of $291.45...
By Sam Boughedda Shares of insulin delivery device maker Insulet (NASDAQ:PODD) have tumbled 12% in early trading Tuesday following a statement from Dexcom (NASDAQ:DXCM) regarding rumors of a...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review